EUVIMEDEUVIMED entdecken
Crossref

The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma

Alessandro Prete, Liborio Torregrossa, Carla Gambale, Raffaele Ciampi, Teresa Ramone, Cristina Romei, Virginia Cappagli, Paolo Piaggi iD, Clara Ugolini, Gabriele Materazzi, Rossella Elisei iD, Antonio Matrone iD

Thyroid® · 2025-04 · 35 (4) · 387-396

DOI: 10.1089/thy.2024.0444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thyroid®, online erschienen am 15.04.2025. Verfasst von Alessandro Prete und 11 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Unit 2, Department of Clinical and Experimental Medicine, Pisa University Hospital, Pisa, Italy. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Neuroendocrine, Neoplasm Grading. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The international medullary thyroid carcinoma (MTC) grading system (IMTCGS) has been proposed as an independent tool to predict disease-specific survival (DSS), distant metastasis-free survival (DMFS), and locoregional recurrence-free survival (LRFS). We aimed to evaluate the performance of IMTCGS in our series of sporadic MTCs and to compare its predictive power with conventional prognostic factors.

Methods

In a retrospective cohort study, we evaluated data from 314 patients with sporadic MTC, all managed at the Pisa University Hospital. We divided patients according to the extent of the disease at diagnosis into localized (183/314, 58.3%) (confined to the thyroid), regional (100/314, 31.8%) (limited to the neck, involving surrounding thyroid tissues and/or regional lymph nodes), and distant (31/314, 9.9%) (distant metastases) disease. Data about somatic mutations were available in 212/314 (67.5%) patients. Expert pathologists differentiated high- and low-grade tumors.

Results

According to the IMTCGS, 115/314 (36.6%) had high- and 199/314 (63.4%) patients had low-grade tumors. Patients with high-grade tumors showed higher preoperative calcitonin levels compared with low-grade (542 vs. 76 pg/mL, p < 0.01) as well as larger tumor size (2.3 vs. 1.1 cm, p < 0.01) and more frequent multifocality (22.6 vs. 12.1%, p = 0.01), minimal extrathyroidal extension (30.4 vs. 9.5%, p < 0.01), and lymph node metastases (63.5 vs. 27.6%, p < 0.01). Overall, patients with high-grade showed lower DSS, LRFS, and DMFS ( p < 0.01). Grouping the whole cohort according to different disease extent at diagnosis, only in the case of localized disease, patients with high-grade tumors had significantly lower LRFS compared with low-grade. Similarly, in the other subgroups, we did not identify any difference in DSS, LRFS, and DMFS. Moreover, in the case of RET aggressive mutations, no differences in DSS, LRFS, and DMFS were observed between high- and low-grade tumors.

Conclusions

We confirmed the usefulness of IMTCGS in predicting DSS, LRFS, and DMFS. However, it finds the best utility in patients with a lower risk of recurrence and mortality, identifying those rare cases with more aggressive clinical behavior. Conversely, when laterocervical lymph nodes (N1), distant metastasis (M1), or RET mutations, particularly M918T or indels , are already present at diagnosis, the role of IMTCGS in predicting DSS, DMFS, and LRFS becomes less relevant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsCarcinoma, NeuroendocrineNeoplasm GradingHumansFemaleMaleMiddle AgedRetrospective StudiesAdultAgedPrognosisYoung AdultMutationDisease-Free SurvivalAdolescentLymphatic MetastasisAged, 80 and over

Stichwörter der Autor:innen

RET genedisease extent at diagnosisinternational medullary thyroid carcinoma grading systemsporadic medullary thyroid carcinoma

Autor:innen und Institutionen

  • Endocrine Unit 2, Department of Clinical and Experimental Medicine, Pisa University Hospital, Pisa, Italy.
  • Pathology Unit 3, Department of Surgical, Medical and Molecular Pathology, Pisa University Hospital, Pisa, Italy.
  • Department of Information Engineering, University of Pisa, Pisa, Italy.
  • Endocrine Surgery Unit - Department of Surgical, Medical and Molecular Pathology and Critical Area, Pisa University Hospital, Pisa, Italy.

ORCID-Profile: Paolo Piaggi, Rossella Elisei, Antonio Matrone

Zitieren

APA

Prete, A., Torregrossa, L., Gambale, C., Ciampi, R., Ramone, T., Romei, C., Cappagli, V., Piaggi, P., Ugolini, C., Materazzi, G., Elisei, R., & Matrone, A. (2025). The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma. Thyroid®, 35(4), 387-396. https://doi.org/10.1089/thy.2024.0444

Vancouver

Prete A, Torregrossa L, Gambale C, Ciampi R, Ramone T, Romei C, et al. The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma. Thyroid®. 2025;35(4):387-396. doi:10.1089/thy.2024.0444

BibTeX
@article{Prete2025,
  author = {Prete, Alessandro and Torregrossa, Liborio and Gambale, Carla and Ciampi, Raffaele and Ramone, Teresa and Romei, Cristina and Cappagli, Virginia and Piaggi, Paolo and Ugolini, Clara and Materazzi, Gabriele and Elisei, Rossella and Matrone, Antonio},
  title = {The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma},
  journal = {Thyroid®},
  year = {2025},
  volume = {35},
  number = {4},
  pages = {387--396},
  doi = {10.1089/thy.2024.0444}
}
Kostenlos starten →